Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.45 |
| ▸ | SLC2A2 | P11168 | 1/20 | 0.45 |
| ▸ | SLC2A3 | P11169 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | UBE2I | P63279 | 3/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 3/20 | 0.41 |
| ▸ | APBA1 | Q02410 | 3/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 3/20 | 0.41 |
| ▸ | UBA2 | Q9UBT2 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17147458 | 0.94 | ALDH1A1 (0.50) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17147437 | 0.93 | UBE2I (0.46) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17147478 | 0.92 | SLC2A1 (0.45) | SLC2A1SLC2A2SLC2A3ALDH1A1HPGD | |
| SCHEMBL17147479 | 0.92 | SLC2A1 (0.52) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17149352 | 0.91 | UBE2I (0.50) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17147511 | 0.90 | SLC2A1 (0.46) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17147442 | 0.88 | SLC2A1 (0.46) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17147455 | 0.88 | ALDH1A1 (0.49) | SLC2A1SLC2A2SLC2A3ALDH1A1USP2 | |
| SCHEMBL17147435 | 0.87 | ALDH1A1 (0.44) | ALDH1A1USP2HPGDKDM4EMAPT | |
| SCHEMBL17147414 | 0.87 | ALDH1A1 (0.53) | ALDH1A1USP2HPGDKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3125884-B1 | SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF | UNIV MICHIGAN REGENTS (US) | 2019-11-06 | — | — | EP | disclosed |
| US-9394303-B2 | Small molecule inhibitors of MCL-1 and uses thereof | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-07-19 | — | — | US | disclosed |
| US-9394303-B2 | Small molecule inhibitors of MCL-1 and uses thereof | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150284387-A1 | SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-08 | — | — | US | disclosed |
| US-20150284387-A1 | SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284387-A1 | SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF | MCL1, BCL2L1, API5 | SLC2A1 4576/4885SLC2A2 4698/4885SLC2A3 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.